Investing in The Cooper Companies, Inc. (COO)  ➔  Intrinsic value

Prev. close$436.60 
ModelValueUpside
Chepakovich$25.64-94%
Graham-Dodd$26.35-94%
Graham$83.18-81%
Previous Close$436.60  
Valuation MethodValuePotential 
Chepakovich Model$25.64-94%recalculate
Graham-Dodd$26.35-94%recalculate
Graham Formula$83.18-81%recalculate

Latest news

Company description

The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive option, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is based in San Ramon, California.